TY  - GEN
AU  - Bose,Prithviraj
AU  - Verstovsek,Srdan
TI  - JAK2 inhibitors for myeloproliferative neoplasms: what is next?
SN  - 1528-0020
PY  - 2017///0815
KW  - Antineoplastic Agents
KW  - therapeutic use
KW  - Bridged-Ring Compounds
KW  - Gene Expression
KW  - Humans
KW  - Janus Kinase 1
KW  - antagonists & inhibitors
KW  - Janus Kinase 2
KW  - Mutation
KW  - Nitriles
KW  - Patient Safety
KW  - Polycythemia Vera
KW  - drug therapy
KW  - Primary Myelofibrosis
KW  - Protein Kinase Inhibitors
KW  - Pyrazoles
KW  - Pyrimidines
KW  - Randomized Controlled Trials as Topic
KW  - Thrombocythemia, Essential
KW  - Treatment Outcome
N1  - Publication Type: Journal Article; Review
UR  - https://doi.org/10.1182/blood-2017-04-742288
ER  -